TCL Archive Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC December 19, 2014
TCL Archive In Brief: Cancer Panel To Meet Aug.29; RFP On Impact Of Planning Cancelled As Being “Premature“ August 15, 1980
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
